Yukihiro Hasegawa
Research Subjects
Research Interests
Yukihiro Hasegawa has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Katsuhiko Tachibana
Division of Endocrinology and Metabolism, Kanagawa Children’s Hospital (K.T.), Japan
2 shared publicationsKatsura Fujii
2 shared publicationsKazumichi Onigata
2 shared publicationsMakoto Yamada
Endocrinology, Metabolism and Genetics Unit (Y.H., K.F., M.Y.), Tokyo Metropolitan Kiyose Children’s Hospital, Tokyo 204
2 shared publicationsShigeaki Kato
Institute of Molecular and Cellular Biosciences, The University of Tokyo (S.K.), Japan
2 shared publicationsToshiaki Tanaka
2 shared publications
Latest Publications
- 1 October 2002
- Published by Wiley in Pediatrics International
- Vol. 44 (5) , 540-542
Infrequent voiding in nephrogenic diabetes insipidus as a cause of renal failure.
- 1 October 2002
- Published by Wiley in Pediatrics International
- Vol. 44 (5) , 540-542
Infrequent voiding in nephrogenic diabetes insipidus as a cause of renal failure.
- Open Access
- 1 October 2000
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 143 (4) , 555-556
Polymorphisms at the 5' end of the human gonadotropin-releasing hormone receptor gene are not associated with the timing of menarche in Japanese girls
- 1 October 2000
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 143 (4) , 555-556
Open AccessPolymorphisms at the 5' end of the human gonadotropin-releasing hormone receptor gene are not associated with the timing of menarche in Japanese girls
- 1 March 2000
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 85 (3) , 1290-1295
Identification of Novel Human GH-1 Gene Polymorphisms that Are Associated with Growth Hormone Secretion and Height
Article published by the Endocrine Society Article published by the Endocrine Society
- 1 March 2000
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 85 (3) , 1290-1295
Identification of Novel Human GH-1 Gene Polymorphisms that Are Associated with Growth Hormone Secretion and Height
Article published by the Endocrine Society Article published by the Endocrine Society
- 1 March 2000
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 85 (3) , 1290-1295
Identification of Novel Human GH-1 Gene Polymorphisms that Are Associated with Growth Hormone Secretion and Height*
Height, which is partially determined by GH secretion, is genetically influenced. The purpose of this study was to identify polymorphisms in the GH-1 gene, which are associated with altered GH production. The subjects included prepubertal short children with GH insufficiency without gross pituitary abnormalities (n = 43), short children with normal GH secretion (n = 46), and normal adults (n = 294). A polymorphism in intron 4 (P-1, A or T at base 1663) was identified. Two additional polymorphic sites (P-2, T or G at base 218, and P-3, G or T at base 439) in the promoter region of the GH-1 gene were also identified and matched with the P-1 polymorphism (A or T, respectively) in more than 90% of the subjects. P-1, P-2, and P-3 were considered to be associated with GH production, and the results of P-2 are explained as a representative in this For example, the allele frequency of T at P-2 in prepubertal short children with GH insufficiency without gross pituitary abnormalities (58.1%) was significantly different from that in short children with normal GH secretion and normal adults (37.0% and 43.5%, respectively; P < 0.001). Furthermore, significant differences were observed in maximal GH peaks in provocative tests (11.1 vs. 18.2 ng/mL, P = 0.006), insulin-like growth factor I sd scores (SDS) (−2.4 vs. −0.8, P < 0.0001), and height (Ht) SDS (−3.7 vs. −3.0, P = 0/001) in children with the T/T or G/G genotypes at P-2, respectively. In the entire study group, significant differences in insulin-like growth factor SDS (T/T,− 0.9; G/G, −0.2; P = 0.0009) and Ht SDS (T/T,− 1.0; G/G, −0.4; P = 0.022) were observed between the T/T and G/G genotypes at P-2. These data indicate that GH secretion is partially determined by polymorphisms in the GH-1 gene, which explain some of the variations in GH secretion and Ht.
- 1 March 2000
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 85 (3) , 1290-1295
Identification of Novel Human GH-1 Gene Polymorphisms that Are Associated with Growth Hormone Secretion and Height*
Height, which is partially determined by GH secretion, is genetically influenced. The purpose of this study was to identify polymorphisms in the GH-1 gene, which are associated with altered GH production. The subjects included prepubertal short children with GH insufficiency without gross pituitary abnormalities (n = 43), short children with normal GH secretion (n = 46), and normal adults (n = 294). A polymorphism in intron 4 (P-1, A or T at base 1663) was identified. Two additional polymorphic sites (P-2, T or G at base 218, and P-3, G or T at base 439) in the promoter region of the GH-1 gene were also identified and matched with the P-1 polymorphism (A or T, respectively) in more than 90% of the subjects. P-1, P-2, and P-3 were considered to be associated with GH production, and the results of P-2 are explained as a representative in this For example, the allele frequency of T at P-2 in prepubertal short children with GH insufficiency without gross pituitary abnormalities (58.1%) was significantly different from that in short children with normal GH secretion and normal adults (37.0% and 43.5%, respectively; P < 0.001). Furthermore, significant differences were observed in maximal GH peaks in provocative tests (11.1 vs. 18.2 ng/mL, P = 0.006), insulin-like growth factor I sd scores (SDS) (−2.4 vs. −0.8, P < 0.0001), and height (Ht) SDS (−3.7 vs. −3.0, P = 0/001) in children with the T/T or G/G genotypes at P-2, respectively. In the entire study group, significant differences in insulin-like growth factor SDS (T/T,− 0.9; G/G, −0.2; P = 0.0009) and Ht SDS (T/T,− 1.0; G/G, −0.4; P = 0.022) were observed between the T/T and G/G genotypes at P-2. These data indicate that GH secretion is partially determined by polymorphisms in the GH-1 gene, which explain some of the variations in GH secretion and Ht.